Wed, May 28, 2025
1- Department of Pathology, Father Muller Medical College, Rajiv Gandhi University of Health Sciences Karnataka, India. , mohitchohil@gmail.com
2- Department of Pathology, Father Muller Medical College, Rajiv Gandhi University of Health Sciences Karnataka, India.
2- Department of Pathology, Father Muller Medical College, Rajiv Gandhi University of Health Sciences Karnataka, India.
Abstract: (273 Views)
Background and objectives: Non-Hodgkin lymphoma represents a heterogenous group of lympho-proliferative malignancies with unique presentation and treatment response. This study was intended to assess the histomorphology of non-Hodgkin lymphoma subtypes and correlate with clinicopathological and immunohistochemical findings.
Methods: A retrospective study was conducted on all samples, diagnosed as non-Hodgkin lymphoma by histopathological analysis, with available immunohistochemical findings. Study was conducted in the department of pathology, for 24 months, during the period of March 2018 to February 2020. The specimens were fixed in 10 % formalin and representative sections were obtained.
Clinical details such as age, gender, location and presentation were recorded. Histopathological and immunohistochemical findings were correlated. Statistical analysis based on p value was performed.
Results: The study includes a total of 48 cases with a male predominance (56.3%). Cervical lymph node (35.4%) was the most common site. Extra nodal presentation was noted in 39.6% of the cases including stomach, testis, hard palate, para-sacral area and para-vertebral area. Diffuse large B-cell lymphoma (43.8%), followed by follicular lymphoma and mantle cell lymphoma were the most common subtypes. A statistically significant p value of 0.05 was obtained.
Conclusion: In our study, we found diffuse large B cell lymphoma (DLBCL) as the most common type of Non Hodgkin’s Lymphoma. Cervical lymph nodes were most common site of involvement. But involvement of sites like the testis and palate were also found, hence the probability of NHL in these rare sites should always to be considered.
Methods: A retrospective study was conducted on all samples, diagnosed as non-Hodgkin lymphoma by histopathological analysis, with available immunohistochemical findings. Study was conducted in the department of pathology, for 24 months, during the period of March 2018 to February 2020. The specimens were fixed in 10 % formalin and representative sections were obtained.
Clinical details such as age, gender, location and presentation were recorded. Histopathological and immunohistochemical findings were correlated. Statistical analysis based on p value was performed.
Results: The study includes a total of 48 cases with a male predominance (56.3%). Cervical lymph node (35.4%) was the most common site. Extra nodal presentation was noted in 39.6% of the cases including stomach, testis, hard palate, para-sacral area and para-vertebral area. Diffuse large B-cell lymphoma (43.8%), followed by follicular lymphoma and mantle cell lymphoma were the most common subtypes. A statistically significant p value of 0.05 was obtained.
Conclusion: In our study, we found diffuse large B cell lymphoma (DLBCL) as the most common type of Non Hodgkin’s Lymphoma. Cervical lymph nodes were most common site of involvement. But involvement of sites like the testis and palate were also found, hence the probability of NHL in these rare sites should always to be considered.
References
1. Roy A, Kar R, Basu D, Badhe BA. The spectrum of histopathologic diagnosis of lymph node biopsies: A descriptive study from a tertiary care center in South India over 5½ years. Indian Journal of Pathology and Microbiology. 2013; 56(2): 103. [View at Publisher] [DOI] [PMID] [Google Scholar]
2. Harris NL, JaffesES, Stein H, Banks PM, Chan JK, Cleary ML, et al. A revised European American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994; 84: 1361-92 [View at Publisher] [DOI] [PMID] [Google Scholar]
3. Gupta V, Singh S, Bhatia Y. Non-Hodgkin's lymphoma: an immunohistochemical analysis with clinicopathological correlation. International Journal of Current Research. 2018; 10(08): 72350-55. [View at Publisher]
4. Yeole BB. Trends in the incidence of Non-Hodgkin's lymphoma in India. Asian Pac J Cancer Prev. 2008; 9(3): 433-6. [View at Publisher] [PMID] [Google Scholar]
5. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin,2005; 55(2):74-108. [View at Publisher] [DOI] [PMID] [Google Scholar]
6. Krenacs L, Bagdi E, Krenacs T. Bancroft Theory and Practice of Histological Techniques. 5th ed. Nottingham. Immunocytopathology of Lymphomas; 517-35
7. Sharma M, Mannan R, Madhukar M, Navani S, Manjari M, Bhasin TS, et al . Immunohistochemical (IHC) Analysis of Non-Hodgkin's Lymphoma (NHL) Spectrum According to WHO/REAL Classification: A Single Centre Experience from Punjab, India. Journal of clinical and diagnostic research. 2014; 8(1): 46-9. [View at Publisher] [DOI] [PMID] []
8. Altieri A, Bermejo JL, Hemminki K. Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database. Blood. 2005; 106(2): 668-72 [View at Publisher] [DOI] [PMID] [Google Scholar]
9. Chang KL, Arber DA, Weiss LM. Lymph nodes and spleen. In: Wick MR, Livolsi VA, Pfeifer JD, Stelow EB, Wakely PE, (eds.) Silverberg's Principles and Practice of Surgical Pathology and Cytopathology. 5th ed. Philedelphia, PA: Elsevier Churchill Livingstone,2015.719- 60.
10. Akhter A, Rahman MR, Majid N, Shermin S, Saleheen MS, Rajib RC, et al. Histological Subtypes of Non-Hodgkin's Lymphoma in Different Age and Sex Groups. Bangladesh Med J. 2012; 41(1):32-6 [DOI] [Google Scholar]
11. Higgins RA, Blankenship JE, Kinney MC. Application of immunohistochemistry in the diagnosis of non-Hodgkin and Hodgkin lymphoma. Archives of pathology & laboratory medicine. 2008; 132(3): 441-61. [View at Publisher] [DOI] [PMID] [Google Scholar]
12. Kalyan K, Basu D, Soundararaghavan J. Immunohistochemical typing of nonHodgkin's lymphoma-comparing working formulation and WHO classification. Indian J PatholMicrobiol. 2006; 49(2): 203-7. [View at Publisher] [PMID] [Google Scholar]
13. Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992- 2001. Blood. 2006; 107(1): 265-76. [View at Publisher] [DOI] [PMID] [Google Scholar]
14. Vallabhajosyula S, Baijal G, Vadhiraja B M, Fernandes DJ, Vidyasagar M S. NonHodgkin's lymphoma: Is India ready to incorporate recent advances in day-to-day practice? J Can Res Ther. 2010; 6: 36-40. [View at Publisher] [DOI] [PMID] [Google Scholar]
15. Padhi S, Paul TR, Challa S, Prayaga AK, Rajappa S, Raghunadharao D, et al. Primary Extra Nodal Non-Hodgkin Lymphoma: A 5 Year Retrospective Analysis. Asian Pacific J Cancer Prev. 2012; 13(10): 4889-95. [View at Publisher] [DOI] [PMID] [Google Scholar]
16. Borgohain M, Krishnatreya K, Weingken C, Das J. Diagnostic Utility of Immunohistochemistry in Lymphoma. International Journal of Contemporary Medical Research. 2020; 4(12): 162-64. [View at Publisher] [Google Scholar]
17. Aggarwal D, Gupta R, Singh S, Kudesia M. Comparison of working formulation and REAL classification of non-Hodgkin's lymphoma: an analysis of 52 cases. Hematology. 2011; 16(4): 195-9. [View at Publisher] [DOI] [PMID] [Google Scholar]
18. Naresh KN, Srinivas V, Soman CS. Distribution of various subtypes of non-Hodgkin's lymphoma in India: a study of 2773 lymphomas using R.E.A.L. and WHO Classifications. Ann Oncol. 2000; 11(1): 63-7 [View at Publisher] [DOI] [PMID] [Google Scholar]
19. El-Esawy BH, Elaskary AA. Clinicopathologic evaluation of different subtypes of Non-Hodgkin's lymphoma according to WHO classification. Life Sci J.2015; 12(1):170-4.
20. Nair R, Arora N, Mallath MK. Epidemiology of NonHodgkin's Lymphoma in India. Oncology. 2016; 91(1):18-25. [View at Publisher] [DOI] [PMID] [Google Scholar]
21. Mushtaq S, Akhtar N, Jamal S, Mamoon N, Khadim T, Sarfaraz T, et al. Malignant lymphomas in Pakistan according to the WHO classification of lymphoid neoplasms. Asian Pac J Cancer Prev. 2008; 9(2): 229-32. [View at Publisher] [PMID] [Google Scholar]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Enamad
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.